Recursion · 7 hours ago
Associate Director, CMC Drug Substance
Recursion is on the cutting edge of drug discovery, generating proprietary maps of biology that provide unique insights, driving target identification, validation, and ultimately novel clinical candidates. We are seeking an Associate Director, CMC Drug Substance to advance our current and future clinical assets through development and ultimately to patients in need.
Responsibilities
Lead external drug substance development across our portfolio including oversight of CDMOs and strategic technical development relationships
Provide technical leadership, project management and oversight of drug substance process development and manufacturing activities supporting Recursion’s clinical programs
Ensure delivery of drug substance from external manufacturing campaigns adhering to current quality guidelines and delivery timelines. Typical travel to external manufacturing sites is 10-20% of the time
Critically analyze process and analytical data to identify and resolve key synthetic challenges during drug substance development
Participate in developing and extending our CDMO relationships, budget planning and forecasting for drug substance expenditures and achieving our quality requirements
Qualification
Required
Ph.D. in organic chemistry or closely related field with a minimum of 5-8 years experience or M.S. with 8-12 years of experience
Strong knowledge and experience in small molecule drug substance process development and manufacturing best practices across all phases of drug development, from initial regulatory filings through registration, validation and launch
Demonstration of cross-functional understanding related to drug substance development including salt/polymorph screening, phase appropriate analytical development, standard process of drug product development, quality and regulatory affairs
Well-versed in the latest trends impacting drug substance technology, manufacturing and the outsourcing industry
Preferred
Prior experience leading external development and CDMO relationships is a plus
Benefits
Annual bonus
Equity compensation
Comprehensive benefits package
Company
Recursion
Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to radically improve lives.
H1B Sponsorship
Recursion has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (5)
2024 (6)
2023 (5)
2022 (2)
2021 (1)
Funding
Current Stage
Public CompanyTotal Funding
$865.38MKey Investors
NVIDIAKinnevikLeaps by Bayer
2024-06-26Post Ipo Equity· $200M
2023-07-12Post Ipo Equity· $50M
2022-10-25Post Ipo Equity· $150M
Recent News
MenloVentures
2025-12-31
Hartford Business Journal
2025-12-30
felicis.com
2025-12-29
Company data provided by crunchbase